Ramsay joint venture in Malaysia

Ramsay Health Care plans to expand its presence in south-east Asia through a $500 million joint venture with Malaysian hospital group Sime Darby.

Ramsay Health Care plans to expand its presence in south-east Asia through a $500 million joint venture with Malaysian hospital group Sime Darby.

The deal, subject to Malaysian regulatory approval, will pool Ramsay's three Indonesian hospitals with Sime Darby's three hospitals and health sciences college.

Ramsay, Australia's biggest private hospital operator, will have a 50 per cent stake in the new Malaysian-based entity at a cost of $120 million over three years.

Chief executive Chris Rex said the deal would allow Ramsay to expand its footprint in surrounding countries.

"They're a big Asian company with a small healthcare business, and we're a big healthcare business with a small presence in Asia," he said.

"It's an opportunity to put those attributes together and use it as a platform to grow the business."

Sime Darby is one of the biggest companies listed on the Bursa Malaysia stock exchange, with a market capitalisation of about $17 billion.

It operates plantations, property, auto, industrial, energy and healthcare businesses in more than 20 countries.

Wilson HTM analyst Shane Storey said further expansion into Asia would help Ramsay offset more stagnant growth in Europe.

"We see this as a positive for the stock - opening a very different corporate avenue for the group to that in Europe, which had grown stale," he said.

Ramsay's Indonesian hospitals brought in $6.07 million in profit before interest and tax for the year to June 2012.

InvestSMART FORUM: Come and meet the team

We're loading up the van and going on tour from April to June, with events on the NSW central & north coast, the QLD mid-north coast and in Perth, Adelaide, Melbourne, Sydney and Canberra. Come and meet the team and take home simple strategies that you can use to build an investment portfolio to weather any storm. Book your spot here.

Want access to our latest research and new buy ideas?

Start a free 15 day trial and gain access to our research, recommendations and market-beating model portfolios.

Sign up for free

Related Articles